Gerald B Appel Selected Research

Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)

1/2022	Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis.
1/2019	Kidney Transplantation in C3 Glomerulopathy: A Case Series.
1/2019	C3 glomerulopathy - understanding a rare complement-driven renal disease.
9/2016	Complement-Mediated Glomerular Diseases: A Tale of 3 Pathways.
2/2014	Toward a working definition of C3 glomerulopathy by immunofluorescence.
1/2013	Membranoprolferative glomerulonephritis - mechanisms and treatment.
7/2012	Pathology after eculizumab in dense deposit disease and C3 GN.
5/2012	Eculizumab for dense deposit disease and C3 glomerulonephritis.
3/2011	Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel.
1/2009	Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerald B Appel Research Topics

Disease

25	Proteinuria 01/2022 - 07/2001
18	Glomerulonephritis 01/2021 - 09/2002
14	Lupus Nephritis 01/2021 - 10/2005
14	Chronic Kidney Failure (Chronic Renal Failure) 09/2016 - 04/2003
12	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2022 - 01/2004
11	IGA Glomerulonephritis (IGA Nephropathy) 01/2021 - 03/2011
9	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2020 - 05/2010
8	Renal Insufficiency (Renal Failure) 01/2022 - 06/2001
8	Nephrotic Syndrome (Syndrome, Nephrotic) 11/2016 - 06/2001
7	Hypertension (High Blood Pressure) 01/2021 - 07/2001
5	Kidney Diseases (Kidney Disease) 01/2022 - 03/2008
4	Fibrosis (Cirrhosis) 01/2018 - 04/2003
4	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2012 - 06/2001
3	Body Weight (Weight, Body) 01/2019 - 11/2011
3	Type 2 Diabetes Mellitus (MODY) 12/2018 - 05/2003
2	Chronic Renal Insufficiency 01/2021 - 12/2018
2	Heart Failure 01/2021 - 05/2014
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 07/2016
2	Diabetic Nephropathies (Diabetic Nephropathy) 12/2015 - 01/2004
2	Paraproteinemias (Monoclonal Gammopathy) 07/2014 - 09/2009
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2012 - 03/2011
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2011 - 10/2005
2	Albuminuria 03/2008 - 02/2008
2	Segmental glomerulosclerosis 02/2008 - 12/2002
2	Cryoglobulinemia 01/2004 - 09/2002
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Hereditary Nephritis (Alport Syndrome) 01/2021
1	Weight Loss (Weight Reduction) 12/2018
1	Thrombotic Thrombocytopenic Purpura 02/2017
1	Hemolytic-Uremic Syndrome 02/2017
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 02/2017
1	Thrombotic Microangiopathies 02/2017
1	Atypical Hemolytic Uremic Syndrome 02/2017
1	Chronic Disease (Chronic Diseases) 02/2015
1	Microscopic Polyangiitis 02/2015
1	Vasculitis (Vasculitides) 02/2015
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 02/2015
1	Anemia 05/2014
1	Nephritis 06/2013

Drug/Important Bio-Agent (IBA)

25	CreatinineIBA 01/2022 - 06/2001
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2001
9	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2012 - 11/2005
8	Immunoglobulin G (IgG)IBA 01/2021 - 01/2004
8	Rituximab (Mabthera)FDA Link 01/2019 - 10/2007
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2012 - 10/2003
6	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 04/2011
6	SteroidsIBA 01/2020 - 09/2008
4	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2004
4	Antigen-Antibody Complex (Immune Complex)IBA 01/2021 - 01/2004
4	Angiotensin IIIBA 01/2015 - 05/2003
4	Immunoglobulin A (IgA)IBA 02/2014 - 03/2011
3	AntibodiesIBA 01/2020 - 02/2008
3	Dichlorodiphenyldichloroethane (DDD)IBA 01/2019 - 01/2009
3	Complement System Proteins (Complement)IBA 01/2019 - 01/2013
3	AngiotensinsIBA 01/2019 - 10/2007
3	Angiotensin Receptor AntagonistsIBA 04/2017 - 09/2004
3	AldosteroneIBA 05/2014 - 02/2008
3	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2013 - 03/2011
3	Azathioprine (Imuran)FDA LinkGeneric 06/2013 - 11/2011
3	LipidsIBA 03/2008 - 05/2003
2	Complement C3 (C3 Complement)IBA 01/2022 - 01/2019
2	bardoxolone methylIBA 01/2021 - 12/2018
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2016
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 01/2015
2	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2018 - 05/2012
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2017 - 05/2014
2	1,2,3,4,6,7,8-heptachlorodibenzodioxinIBA 07/2014 - 07/2001
2	Immunoglobulin M (IgM)IBA 02/2014 - 06/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2013 - 10/2007
2	eculizumab FDA Link 07/2012 - 05/2012
2	NPHS2 proteinIBA 09/2008 - 12/2002
2	LDL CholesterolIBA 03/2008 - 05/2003
2	Losartan (Cozaar)FDA LinkGeneric 03/2008 - 05/2003
2	Pamidronate (Aredia)FDA LinkGeneric 03/2003 - 06/2001
1	HLA-DQ5 antigenIBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	HLA-DQ6 antigenIBA 01/2022
1	HLA-DR15 antigenIBA 01/2022
1	AlbuminsIBA 01/2021
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2021
1	Hydralazine (Apresoline)FDA LinkGeneric 01/2021
1	HLA-A3 Antigen (HLA A3 Antigen)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	ParaproteinsIBA 01/2020
1	AntigensIBA 01/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2018
1	Interferon-gamma (Interferon, gamma)IBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Shiga Toxin (Shigella Toxin)IBA 02/2017
1	LectinsIBA 09/2016
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2016
1	Abatacept (Orencia)FDA Link 12/2015
1	Monoclonal AntibodiesIBA 01/2015
1	Proteasome InhibitorsIBA 07/2014
1	Bortezomib (Velcade)FDA Link 07/2014

Therapy/Procedure

34	Therapeutics 01/2021 - 06/2001
5	Kidney Transplantation 01/2021 - 05/2008
2	Glycemic Control 12/2018 - 05/2003
1	Duration of Therapy 06/2013